retatrutide what is it clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II Eli Lilly infiltrates anti-obesity market
Description
Forcing yourself to eat is usually not helpful
The most common side effects of GLP-1 medications include nausea and vomiting, diarrhea, constipation, abdominal pain, bloating, dizziness, and fatigue
This makes it a valuable tool for patients struggling with obesity or related conditions such as type 2 diabetes
But its only because the GLP-1s have been so effective, and the amount of weight loss that one can achieve has been so great
By uncovering patient and clinician perspectives on sustainability, and testing adoption pathways for greener alternatives, our research delivers the insights needed to drive smarter innovation and strategy
PMID: 36841762
